Interstitial Lung Disease

Because interstitial lung disease is often associated with an older patient population, there is limited knowledge on how ILD impacts young women who are pregnant, according to a review published in CHEST.

Patients with systemic sclerosis who report more severe reflux symptoms demonstrate worse interstitial lung disease outcomes despite receiving standard therapy, according to data published in Arthritis Care & Research.

The FDA has granted Orphan Drug Designation to belimumab, a B-cell inhibiting monoclonal antibody, for the potential treatment of systemic sclerosis, according to a press release from GlaxoSmithKline.

Compared with high-resolution CT, chest radiography appeared less accurate in detecting interstitial lung disease, according to a study published in Annals of the American Thoracic Society.

Compared with visual assessment, a deep learning model improved CT imaging prediction of histopathologic usual interstitial pneumonitis in patients with interstitial lung disease, according to study results published in CHEST.

Among the top takeaways from the CHEST 2022 Annual Meeting, held Oct. 16 to 19 in Nashville, Tennessee, were diversity in content and speakers, addressing disparities and new initiatives, according to Subani Chandra, MD, FCCP.

Among patients previously hospitalized with COVID-19, researchers estimated that up to 11% had fibrotic patterning, according to a study published in American Journal of Respiratory and Critical Care Medicine.

In patients with nonvalvular atrial fibrillation receiving oral anticoagulants, factor Xa inhibitors appeared associated with increased risk for interstitial lung disease, according to a study published in JAMA Network Open.

With advanced X-rays and blood biomarkers, researchers have found how lung tissue scarring in patients with COVID and pulmonary fibrosis forms a distinctive form of fibrotic interstitial lung disease, according to a study in eBioMedicine.

PHILADELPHIA — Rituximab is comparable in terms of safety and efficacy to cyclophosphamide among patients with interstitial lung disease associated with connective tissue diseases, according to data presented at ACR Convergence 2022.